Overview
Gregg Shepard is an Oncologist in Nashville, Tennessee. Dr. Shepard is highly rated in 44 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Hemochromatosis, Iron Deficiency Anemia, and Drug-Induced Thrombocytopenia.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4220 Harding Pike Ste 200, Nashville, TN 37205
4230 Harding Pike Ste 707, Nashville, TN 37205
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
SCRI Oncology Partners Group
Erika Hamilton is an Oncologist in Nashville, Tennessee. Dr. Hamilton is highly rated in 23 conditions, according to our data. Her top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Ovarian Cancer, and HER-2 Positive Breast Cancer. Dr. Hamilton is currently accepting new patients.
SCRI Oncology Partners Group
David Spigel is an Oncologist in Nashville, Tennessee. Dr. Spigel is highly rated in 29 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Spigel is currently accepting new patients.
SCRI Oncology Partners Group
Denise Yardley is an Oncologist in Nashville, Tennessee. Dr. Yardley is highly rated in 22 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Paget Disease of the Breast. Dr. Yardley is currently accepting new patients.
Frequently Asked Questions about Dr. Gregg Shepard
How do I make an appointment with Dr. Gregg Shepard?
You can book an appointment with Dr. Gregg Shepard by calling their office at 615-385-3751. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gregg Shepard a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregg Shepard is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gregg Shepard specialize in?
While Dr. Gregg Shepard is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Hemochromatosis, and Iron Deficiency Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Gregg Shepard participate in research or clinical trials?
Yes. Dr. Gregg Shepard has published 3 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Gregg Shepard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gregg Shepard accept my insurance?
Dr. Gregg Shepard accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 615-385-3751 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pleuropulmonary BlastomaDr. Shepard isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Acute Mountain SicknessDr. Shepard isAdvanced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Shepard isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Shepard isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Shepard isAdvanced. Learn about Anemia.
- Breast CancerDr. Shepard isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Shepard isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shepard isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Adult Soft Tissue SarcomaDr. Shepard isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Shepard isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Shepard isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Shepard isExperienced. Learn about Anal Cancer.
- Anaplastic Large Cell LymphomaDr. Shepard isExperienced. Learn about Anaplastic Large Cell Lymphoma.